Myotubular myopathy and the neuromuscular junction: a novel therapeutic approach from mouse models.
about
Pathogenic mechanisms in centronuclear myopathiesSkeletal Muscle Pathology in X-Linked Myotubular Myopathy: Review With Cross-Species ComparisonsPathophysiological concepts in the congenital myopathies: blurring the boundaries, sharpening the focusIn vivo imaging of skeletal muscle in mice highlights muscle defects in a model of myotubular myopathy.Antisense oligonucleotide-mediated Dnm2 knockdown prevents and reverts myotubular myopathy in mice.SPEG interacts with myotubularin, and its deficiency causes centronuclear myopathy with dilated cardiomyopathyCentronuclear myopathy in Labrador retrievers: a recent founder mutation in the PTPLA gene has rapidly disseminated worldwide.Peripheral nerve and neuromuscular junction pathology in Pompe diseaseTriadopathies: an emerging class of skeletal muscle diseases.Correcting Neuromuscular Deficits With Gene Therapy in Pompe DiseaseMuscle pathology, limb strength, walking gait, respiratory function and neurological impairment establish disease progression in the p.N155K canine model of X-linked myotubular myopathy.Intravenous Administration of a MTMR2-Encoding AAV Vector Ameliorates the Phenotype of Myotubular Myopathy in Mice.Single Intramuscular Injection of AAV-shRNA Reduces DNM2 and Prevents Myotubular Myopathy in Mice.Treating pediatric neuromuscular disorders: The future is now.Centronuclear myopathies under attack: A plethora of therapeutic targetsTamoxifen prolongs survival and alleviates symptoms in mice with fatal X-linked myotubular myopathyTamoxifen therapy in a murine model of myotubular myopathy
P2860
Q21131067-347A2FCD-FADB-4F47-B342-F5001581C5FFQ26773024-48BB7570-05EE-454E-A1E6-A9D2E207EF88Q28087567-6F9E3C9D-9DD6-49C6-B439-D10991BD4F4BQ30834629-AF5D970C-48A3-4AB2-A8BE-31D772310EB6Q30855431-15BB469C-BC56-44A1-B302-A68833B338E9Q34030749-85929EC3-5136-4B67-B483-2DA2A296C063Q34447103-99C4F9D3-1FE7-4A2B-B064-DFC77AB46D07Q34920690-57236273-859D-47B7-BC5D-DB7A496BCF92Q35340211-52F799B8-4DFF-4D92-B22E-9CEF70EBED31Q35903220-26B4344B-1D56-46F6-9491-8D562F5B33B5Q36241876-709C97C3-C2C8-4E54-B907-10DF695F5B85Q50161380-A4A5A7F2-7248-42DF-B49B-1C95CC7CE57AQ51744193-0B2C72D0-EB16-4D4B-B361-6984707AD10AQ52756417-736319E7-C755-48EE-B119-9BC0562C63ADQ58713722-2FB873B1-CA54-4DF6-A72A-40ACD628F5DAQ59125219-04EA99FE-F1F8-4D99-8919-45AB0A2FEACAQ59134779-C9D58FDC-BF87-4CD8-ACC6-C7BB46DBBEAA
P2860
Myotubular myopathy and the neuromuscular junction: a novel therapeutic approach from mouse models.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Myotubular myopathy and the ne ...... ic approach from mouse models.
@ast
Myotubular myopathy and the ne ...... ic approach from mouse models.
@en
type
label
Myotubular myopathy and the ne ...... ic approach from mouse models.
@ast
Myotubular myopathy and the ne ...... ic approach from mouse models.
@en
prefLabel
Myotubular myopathy and the ne ...... ic approach from mouse models.
@ast
Myotubular myopathy and the ne ...... ic approach from mouse models.
@en
P2093
P2860
P356
P1476
Myotubular myopathy and the ne ...... tic approach from mouse models
@en
P2093
Andrew D Snyder
Anna Buj-Bello
Ashley N Dulin-Smith
Ashley N Durban
Christopher R Pierson
James J Dowling
Jordan T Marshall
Morgan L Marshall
Nadia Messaddeq
Sean E Low
P2860
P304
P356
10.1242/DMM.009746
P577
2012-05-24T00:00:00Z